• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: W.L. GORE & ASSOCIATES GORE HELEX SEPTAL OCCLUDER; OCCLUDER, TRANSCATHETER SEPTAL

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

W.L. GORE & ASSOCIATES GORE HELEX SEPTAL OCCLUDER; OCCLUDER, TRANSCATHETER SEPTAL Back to Search Results
Catalog Number HX2020
Device Problem Malposition of Device (2616)
Patient Problem No Information (3190)
Event Date 07/04/2014
Event Type  Injury  
Event Description
It was reported the physician implanted a 20mm gore helex septal occluder to close a multifenestrated atrial septal defect.The patient¿s septal length measured 23mm, and deficient inferior and superior rims were noted.At the time of implant, images showed a residual shunt.The day after implant, echocardiography showed the device had shifted and was impinging the mitral valve.The patient was sent for surgery where the device was removed and the defect was repaired.The patient was doing well following the procedure.
 
Manufacturer Narrative
A review of the manufacturing records verified the lot was processed normally and all pre-release specifications were met.
 
Manufacturer Narrative
The device was returned for analysis.The size and shape of the occluder were unremarkable.All leaflet material was present and the wire frame was intact.Based on inspection of this device, there is no indication that the reported event was due to design or manufacture of the device.Echocardiographic images and fluoroscopic images were received for evaluation.Intracardiac echocardiographic images on the day of implant demonstrated the atrial septum was thin, aneurysmal, and multi fenestrated.Posterior superior and anterior inferior rims were present and the anterior superior rim was mildly deficient.A 20mm gore helex septal occluder was implanted.A post implant fluoroscopic image revealed part of the right disc was positioned on the left side of the septum.The occluder was in a stable position with a mild superior residual leak.The following day, transthoracic echocardiography revealed the 20mm gore helex septal occluder had embolized into the left atrium and impinged on the mitral valve.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
GORE HELEX SEPTAL OCCLUDER
Type of Device
OCCLUDER, TRANSCATHETER SEPTAL
Manufacturer (Section D)
W.L. GORE & ASSOCIATES
flagstaff AZ
Manufacturer (Section G)
KENDRICK PEAK MPD B/P
4250 w. kiltie lane
flagstaff AZ 86001
Manufacturer Contact
marci stewart
1500 n. 4th street
flagstaff, AZ 86004
9285263030
MDR Report Key3954086
MDR Text Key4627957
Report Number2017233-2014-00367
Device Sequence Number1
Product Code MLV
Combination Product (y/n)N
Reporter Country CodeUS
PMA/PMN Number
P050006
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Company Representative
Reporter Occupation Physician
Type of Report Initial,Followup
Report Date 08/19/2014
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received07/23/2014
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Health Professional
Device Expiration Date06/30/2016
Device Catalogue NumberHX2020
Device Lot Number11670463
Was Device Available for Evaluation? Device Returned to Manufacturer
Date Returned to Manufacturer07/25/2014
Is the Reporter a Health Professional? Yes
Was Device Evaluated by Manufacturer? Yes
Date Device Manufactured08/05/2013
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Patient Outcome(s) Required Intervention;
Patient Weight4
-
-